Bombardier mène à bien le rachat partiel de ses billets de premier rang 7,875 % échéant en 2027 d’un capital de 200 000 000 $ US
April 22, 2024 17:01 ET
|
Bombardier Inc.
MONTRÉAL, 22 avr. 2024 (GLOBE NEWSWIRE) -- Bombardier Inc. (« Bombardier ») a annoncé aujourd’hui le rachat de ses billets de premier rang 7,875 % échéant en 2027 d’un capital de...
Bombardier Completes Partial Redemption of US$200,000,000 of its 7.875% Senior Notes due 2027
April 22, 2024 17:01 ET
|
Bombardier Inc.
MONTRÉAL, April 22, 2024 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has redeemed US$200 million principal amount of its outstanding 7.875% Senior Notes due 2027...
Scorpius Holdings Announces Receipt of Filing Delinquency Notification
April 22, 2024 17:00 ET
|
Scorpius Holdings, Inc.
DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), received an official notice...
Mountaineer Partners Delivers Open Letter to the Board of Directors of Vishay Intertechnology, Inc.
April 22, 2024 09:00 ET
|
Mountaineer Partners Management, LLC
Mountaineer Partners delivers a letter to Vishay Intertechnology calling for the Company to use excess cash to adopt a $600 million share repurchase plan.
Cidara Therapeutics Announces Reverse Stock Split
April 22, 2024 08:49 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
Mithra secures court protection measures to advance monetization process
April 22, 2024 01:00 ET
|
Mithra Pharmaceuticals
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 19, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
April 19, 2024 17:10 ET
|
ASLAN PHARMACEUTICALS LIMITED
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
AIP Realty Trust Closes First Tranche of a Non-Brokered Offering
April 19, 2024 17:01 ET
|
AIP Realty Trust
VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- AIP Realty Trust (the “Trust” or “AIP”) (TSXV: AIP.U) today announces that it has completed the first tranche of a non-brokered...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 19, 2024 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...